FocusCurve: ADHD Medication Crash Management Platform
Extended-release ADHD medications like Concerta often wear off prematurely (e.g., around 3 PM), inducing severe exhaustion, brain fog, and a sharp drop in performance exactly when patients have late-day exams, lectures, or work assignments.
Is the problem real?
ADHD patients taking Concerta experience severe afternoon exhaustion (crashing) before their required daily tasks or exams are finished.
EVIDENCE
How do I prevent the afternoon crash from concerta
How do I prevent the afternoon crash from concerta
"use the 18mg as a 'top up' dose which I take about 12/1pm to get me through the rest of the afternoon"
commentI'm on 72mg Concerta. Not sure where you are based but in the UK they prescribe this dose as 54mg and 18mg. Instead of taking these both together in the morning, I tend to take 54mg in the morning and use the 18mg as a "top up" dose which I take about 12/1pm to get me through the rest of the afternoon, as I also tend to crash about 3pm.
Who feels this pain?
TARGET USERS
Individuals taking extended-release stimulants like Concerta who need to maintain focus for late-day exams or tasks but consistently hit a severe cognitive energy crash around mid-afternoon.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Explicitly flagged by multiple users on the same medication dosage experiencing identical midday exhaustion timelines.
Unlike generic ADHD habit trackers, FocusCurve specifically targets the pharmacokinetics of stimulant breakdown, framing data entirely around metabolic crash prevention and providing structured assets for physician communication.
A mobile application and clinical decision support tool that tracks a user's specific medication timeline, predicts their daily 'crash window' using digital biomarkers, and provides data-backed, physician-reviewed scheduling protocols (such as optimized ingestion timing, behavioral countermeasures, and doctor-facing reports to request compliant afternoon boosters).
How does it make money?
MONETIZATION
Model
Users express extreme desperation over failing exams and performing terribly due to afternoon exhaustion; saving a single academic grade or billable work hour easily justifies a sub-$10 monthly expense.
How do you ship it?
MVP PLAN
“Predict and prevent your 3 PM medication crash before it ruins your day.”
A mobile application and clinical decision support tool that tracks a user's specific medication timeline, predicts their daily 'crash window' using digital biomarkers, and provides data-backed, physician-reviewed scheduling protocols (such as optimized ingestion timing, behavioral countermeasures, and doctor-facing reports to request compliant afternoon boosters).
Core Features
Weekly Roadmap
- •Build mobile-responsive UI for medication dosage input and crash logging
- •Implement basic math engine estimating medication levels based on standard Concerta half-life
- •Set up user authentication and secure profile storage
- •Create the dynamic timeline graph showing expected crash windows
- •Integrate automated local push notifications alerting users prior to crash zones
- •Develop structured fields for recording physical symptoms during crashes
- •Implement a 'Generate Physician Report' PDF export engine
- •Integrate Stripe billing webhooks for basic paywall gate
- •Onboard 20 ADHD students from Reddit/X to a private TestFlight beta
- •Publish landing page detailing optimization strategies
- •Launch application publicly on r/ADHD and related subreddits
- •Monitor initial user conversions and premium subscription analytics
Partner with digital ADHD student communities, execute targeted SEO around 'Concerta 3pm crash' or 'ADHD afternoon exhaustion', and run influencer campaigns with neurodivergent creators on TikTok/X.
RISKS & ASSUMPTIONS
Top Risks
Providing guidance on medication schedules could cross into unregulated medical advice; the platform must strictly act as an analytical tracking log and education tool.
Users with ADHD frequently abandon tracking apps after a few days of novelty, requiring highly gamified or ultra-low-friction logging workflows.
Different metabolisms, diet, and sleep affect medication curves, making standard algorithms inaccurate without precise user-input calibrations.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "analytics", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "FocusCurve: ADHD Medication Crash Management Platform" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.